Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Benef Microbes ; 11(6): 547-559, 2020 Oct 12.
Artigo em Inglês | MEDLINE | ID: mdl-33032472

RESUMO

Hyperoxaluria is a pathological condition which affects long-term health of kidneys. The present study evaluates the impact of the combination of Lactobacillus amylovorus SGL 14 and the plant extract Phyllantus niruri (namely Phyllantin 14™) on dietary hyperoxaluria. Safety and efficacy of Phyllantin 14 have been evaluated in vivo. Mice C57BL6 fed a high-oxalate diet were compared to mice fed the same diet administered with Phyllantin 14 by gavage for 6 weeks. Control mice were fed a standard diet without oxalate. No adverse effects were associated to Phyllantin 14 supplementation, supporting its safety. Mice fed a high-oxalate diet developed significant hyperoxaluria and those administered with Phyllantin 14 showed a reduced level of urinary oxalate and a lower oxalate-to-creatinine ratio. Soluble and insoluble caecal oxalate were significantly lower in treated group, a finding in agreement with the colonisation study, i.e. mice were colonised with SGL 14 after 3 weeks. Microbiota analysis demonstrated that both oxalate diet and Phyllantin 14 can differently modulate the microbiota. In conclusion, our findings suggest that Phyllantin 14 supplementation represents a potential supportive approach for reducing urinary oxalate and/or for enhancing the efficacy of existing treatments.


Assuntos
Dieta , Hiperoxalúria/terapia , Lactobacillus acidophilus , Oxalatos/administração & dosagem , Phyllanthus , Extratos Vegetais/uso terapêutico , Animais , Aderência Bacteriana , Ceco/química , Modelos Animais de Doenças , Fezes/química , Microbioma Gastrointestinal , Células HT29 , Humanos , Hiperoxalúria/tratamento farmacológico , Hiperoxalúria/patologia , Rim/patologia , Lactobacillus acidophilus/crescimento & desenvolvimento , Lactobacillus acidophilus/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Oxalatos/análise , Oxalatos/urina , Fitoterapia , Probióticos
2.
Anal Bioanal Chem ; 393(2): 709-18, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18982317

RESUMO

An analytical procedure for the simultaneous determination in human plasma and oral fluids of several illicit drugs belonging to different chemical and toxicological classes is presented. Amphetamine, methamphetamine, morphine, 6-monoacetylmorphine, methylenedioxyamphetamine, methylenedioxyethylamphetamine, methylenedioxymethamphetamine, cocaine, benzoylecgonine, tetrahydrocannabinol, carboxytetrahydrocannabinol, ketamine, and phencyclidine have been quantified in real samples using a very rapid sample treatment, basically a protein precipitation. The quantitative analysis was performed by liquid chromatography-tandem mass spectrometry and has been fully validated. All the analytes were detected in positive ionization mode using a TurboIonSpray source, except carboxytetrahydrocannabinol, which was detected in negative ionization mode. The use of a diverter valve between the column and the mass spectrometer allows the preservation of the ion source performances for high-throughput analysis.


Assuntos
Líquidos Corporais/química , Cromatografia Líquida de Alta Pressão/métodos , Drogas Ilícitas/sangue , Espectrometria de Massas em Tandem/métodos , 3,4-Metilenodioxianfetamina/sangue , Anfetamina/sangue , Calibragem , Cocaína/análogos & derivados , Cocaína/sangue , Dronabinol/análogos & derivados , Dronabinol/sangue , Humanos , Ketamina/sangue , Metanfetamina/sangue , Morfina/sangue , Derivados da Morfina/sangue , N-Metil-3,4-Metilenodioxianfetamina/sangue , Fenciclidina/sangue , Sensibilidade e Especificidade , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA